Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-3 of 3
Keywords: miR-202
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Bioscience Reports
Biosci Rep (2022) 42 (11): BSR-2019-0680_RET.
Published: 23 November 2022
... © 2022 The Author(s). 2022 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . cell invasion cell migration endometrial carcinoma FGF2 miR-202...
Articles
Ping Chen, Tianrong Xing, Qingdong Wang, Ai Liu, Haiping Liu, Yuhong Hu, Yanjia Ji, Ying Song, Dongwei Wang
Journal:
Bioscience Reports
Biosci Rep (2019) 39 (10): BSR20190680.
Published: 11 October 2019
...Ping Chen; Tianrong Xing; Qingdong Wang; Ai Liu; Haiping Liu; Yuhong Hu; Yanjia Ji; Ying Song; Dongwei Wang Recently, many mircroRNAs (miRNAs) involved in the development and progression of cancer have been reported to regulate cell growth and metastasis, including microRNA-202 (miR-202...
Articles
Journal:
Bioscience Reports
Biosci Rep (2018) 38 (3): BSR20171383.
Published: 08 May 2018
... of CML due to its high efficacy and low toxicity. However, the development of imatinib resistance limits the long-term treatment benefits of it in CML patients. In the present study, we aimed to investigate the roles of miR-202 in the regulation of imatinib sensitivity in CML cell lines and the possible...
